As trials grow more complex, connected technologies are strengthening oversight, coordination, and data integrity across the clinical trial ecosystem.
By Deepak Prakash, VP Healthcare at Identiv
Over the last decade, digital transformation has reshaped nearly every aspect of daily life. Advances in smartphones, cloud computing, connected devices, and artificial intelligence have created seamless, data-rich experiences for consumers. Clinical research, which operates at the intersection of scientific complexity, regulatory rigor, and compliance, is undergoing a similar shift1.
Much of the public conversation around digital transformation in clinical research centers on artificial intelligence, decentralized trials, and advanced analytics. Yet one of the most significant shifts has occurred in operations: how samples are tracked, how patients move through complex workflows, how investigational products are managed, and how data flows across stakeholders. As trials become increasingly global, decentralized, and data-intensive, operational excellence has evolved from a supporting function to a strategic differentiator.
The transition to a digitally enabled ecosystem represents a structural rethinking of how trials are planned, executed, monitored, and scaled.
Patient Engagement and Adherence
Medication adherence remains one of the biggest challenges that pharmaceutical companies deal with2 and the issue is often amplified during decentralized clinical trials. When patients are dispersed across geographies and interacting with sites remotely, monitoring adherence becomes both more difficult and more critical to study integrity.
Smart packaging technologies have emerged as a practical solution. By integrating sensors, data capture, and digital identifiers directly into packaging formats such as vials and auto-injectors, sponsors can gain visibility into dosing behavior, tampering events, and environmental conditions. Technologies such as RFID and Bluetooth-enabled monitoring allow real-time or near-real-time data capture, improving both patient engagement and operational oversight. These solutions are robust and scalable and can be cost-effective when deployed in various common form factors.
In one recent implementation, a leading pharmaceutical company3 deployed smart packaging technology to evaluate its impact on patient engagement and overall trial efficiency. The results demonstrated how connected packaging can support adherence monitoring while reducing manual intervention and data gaps.
Simplifying Clinical Trials Operations
Clinical trials today are markedly more complex than they were two decades ago. Precision medicine, biomarker-driven eligibility criteria, adaptive protocols, and global site networks have increased both logistical and regulatory demands. Rare disease trials, for example, often require intricate sample handling, time-sensitive processing, and multi-layered data reconciliation across borders.
Common operational challenges include:
- Multi-country regulatory variation
- Fragmented technology stacks
- Manual data entry and reconciliation
- Delays in biological sample processing
- Patient drop-off due to logistical burden
- Limited real-time visibility into site performance
Digital transformation has the potential to address these through integrated systems, automation, and real-time transparency. When systems are connected end-to-end – from site workflows to central labs to sponsors – data silos shrink and error rates decline.
Improving Efficiency
As clinical trials have evolved in size, scope and complexity, operational strain has increased. Yet many workflows still rely on manual processes and fragmented communication. For example, specimen management remains a particular vulnerability, with risks ranging from lost samples to temperature excursions affecting sensitive materials.
Established technologies such as RFID tagging offer enhanced durability and automated data capture compared to traditional barcodes and QR codes. Recent advancements in Bluetooth-enabled labels now integrate environmental sensors capable of monitoring temperature, humidity, and other critical parameters – particularly important for condition-sensitive drugs and biological samples.
Leveraging these technologies for real-time tracking improves chain-of-custody visibility and enables more seamless data exchange among sites, logistics providers, laboratories, and sponsors. When combined with AI-driven analytics, these systems can identify bottlenecks proactively, enabling corrective action before delays escalate.
Product Logistics
Operational transformation extends beyond data and samples to investigational product logistics.
Modern digital supply chain systems now support:
- Real-time temperature monitoring
- Automated resupply triggers
- Smart packaging tracking
- Geofenced shipment alerts
These capabilities reduce drug wastage, support Good Clinical Practice (GCP) compliance, and minimize last-minute resupply emergencies. Integration with patient scheduling platforms further aligns supply availability with visit timing, reducing research site burden and improving coordination.
Product Labeling and Accessibility
Digitalization is also reshaping product labeling. Enhanced labels can now incorporate spoken audio and custom text with the tap of a smartphone, haptic feedback, and high-contrast text, expanding accessibility across diverse patient populations. In decentralized trials, where patients often self-administer treatments at home, accessible labeling can significantly improve usability and adherence.
Conventional technologies such as Optical Character Recognition (OCR), when integrated with AI, further enhance accessibility by enabling digital reading, translation, and interaction features – strengthening both inclusivity and data integrity.
Building the Digital Backbone of Clinical Research
As clinical trials become more global, decentralized, and data-driven, complexity is unlikely to diminish. What is changing is how that complexity is managed.
A well-designed digital transformation strategy – grounded in integrated infrastructure rather than isolated tools – can streamline operations, enhance patient experience, and reduce workflow burden.
Technologies such as RFID and Bluetooth-enabled tagging form part of a scalable foundation for modern trial execution. When combined with intelligent analytics, these systems move organizations from reactive problem-solving to proactive optimization.
Operational bottlenecks will always exist within research ecosystems. But with deliberate deployment of connected technologies and automation, sponsors can reduce inefficiencies, improve data quality, and strengthen the economics of innovation.
References:
- Digital Transformation: A new era for clinical trials, IQVIA Whitepaper, 2024
- Improving patient adherence through data-driven insights, McKinsey, 2018
- Can smart technology help transform clinical trials, Takeda, 2024
